Why Teladoc Stock Is Plummeting Today

Teladoc (NYSE: TDOC) stock is sinking in Thursday's trading on the heels of the company's recent fourth-quarter release. The telehealth specialist's share price was down 11.7% as of 2:45 p.m. ET and had been off as much as 19.7% earlier in the daily session.

Teladoc published its Q4 results after the market closed yesterday, delivering a mixed report. While the company's sales came in ahead of Wall Street's expectations, the business posted a wider-than-anticipated loss. Management's guidance for this year also underwhelmed investors.

Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »

Teladoc stock tumbles on wider-than-expected Q4 loss

Teladoc posted another quarter of sales declines in Q4, with revenue declining 3% year over year in the period. The business recorded a loss of $0.28 per share on revenue of $640.49 million in the quarter. For reference, the consensus Wall Street estimated had called for a loss of $0.22 per share on revenue of $639.44 million.

Teladoc's integrated care customer count actually increased 5% year over year in Q4, but average revenue per user declined 2%. With signs of weakening pricing power and a loss that came in bigger than anticipated, investors are selling out of the telehealth stock today.

What's next for Teladoc?

Teladoc is guiding for sales to come in between $2.468 billion and $2.576 billion this year. The midpoint of the company's guidance range suggests a roughly 1.9% decline from the sales of roughly $2.57 billion it posted last year. Meanwhile, the company guided for its annual loss per share to come in between $0.50 and $1.10 -- improving from last year's loss of $5.87 per share.

While Teladoc is cutting costs and reducing its losses, the company's growth engine has stalled -- and it's not clear what catalysts on the near horizon might be capable of reinvigorating it. Following botched acquisitions and massive write-downs over the last five years, the company's path to profitability and healthy sales growth looks challenging.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

• Nvidia: if you invested $1,000 when we doubled down in 2009, you’d have $340,411!*
• Apple: if you invested $1,000 when we doubled down in 2008, you’d have $45,570!*
• Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $533,931!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

Learn more »

*Stock Advisor returns as of February 24, 2025

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Teladoc Health. The Motley Fool has a disclosure policy.